作者
Richard L. Theriault,R. W. Carlson,Craig Allred,Benjamin O. Anderson,Harold J. Burstein,Stephen B. Edge,William B. Farrar,Andres Forero,Sharon H. Giordano,Lori J. Goldstein,William J. Gradishar,Daniel F. Hayes,Clifford A. Hudis,Steven J. Isakoff,Britt Marie Ljung,David A. Mankoff,P. Kelly Marcom,Ingrid A. Mayer,Beryl McCormick,Lori J. Pierce,Elizabeth Reed,Lee S. Schwartzberg,Mary Lou Smith,Hatem Soliman,George Somlo,John H. Ward,Antonio C. Wolff,Richard C. Zellars,Dorothy A. Shead,Rashmi Kumar
摘要
These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.